[{"Assets_0_Q2_USD":"6145841000.0","CIK":"1048477","CommonStockSharesIssued_0_Q2_shares":"185452454.0","CommonStockSharesOutstanding_0_Q2_shares":"185452454.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.15","EarningsPerShareBasic_2_Q2_USD":"0.8","EarningsPerShareDiluted_1_Q2_USD":"0.15","EarningsPerShareDiluted_2_Q2_USD":"0.79","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"10795000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"27664000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"148462000.0","NetIncomeLoss_1_Q2_USD":"27664000.0","NetIncomeLoss_2_Q2_USD":"148462000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q2_USD":"533798000.0","RevenuesConverted_2_Q2_USD":"1053157000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"4504807000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"187448000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"191096000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"185254000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"184710000.0","filed":"20220804","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20220630","qtrs":"0","uom":"shares"}]